- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Keller and Heckman LLP and NanoReg® are hosting a nanoregulation workshop on March 20, 2008 in Baltimore, Maryland. This conference is immediately following the Global Chemical Regulations Conference at the Marriott Baltimore Waterfront Hotel.
In response to the tremendous interest in, and recent policy announcements on, nanotechnology environmental, health and safety (EHS) issues, Keller and Heckman and NanoReg® have created an agenda to guide the chemical industry through these new developments.
These changes include strategic plans being developed by the National Nanotechnology Initiative (NNI), the Office of Science and Technology Policy (OSTP), and the Council on Environmental Quality (CEQ) regarding policies and priorities for nanotechnology EHS research and oversight. Also included is The Organisation for Economic Co-operation and Development's recently-announced plan to test a representative set of manufactured nanomaterials.
This is the conference to attend to assess how nanotechnology is being managed and how it will develop in the future for EHS purposes.
Nanotechnology presents your business with opportunities to develop an array of exciting new products with enhanced or fundamentally different performance properties. This one-day session will feature leaders in public policy who will share their views on corporate and regulatory governance related to developing an environmental, health and safety (EHS) framework for the products of the future.
Confirmed speakers for the conference include: Conference hosts Martha Marrapese, Partner, Keller and Heckman LLP and John DiLoreto, Founder, NanoReg®, as well as guest speakers, Dr. Richard Canady, Office of the Commissioner, FDA; Dr. Kenneth Mundt, Principal, ENVIRON®; Jim Willis, Division Director, Environmental Protection Agency; Terry Medley, Director of Global Regulatory Affairs, DuPont and Mike Novak, Partner, Keller and Heckman LLP.
About Keller and Heckman LLP
Keller and Heckman LLP, founded in 1962, has a broad practice in the areas of regulatory law, litigation, and business transactions, serving both domestic and international clients. Our firm is a pioneer in the use of interdisciplinary approaches to problem-solving. Since 1971, we have had an in-house scientific staff that works closely with the firm's attorneys on matters of technical complexity. Many of our attorneys also have government experience and expertise in multiple areas of the law.
Keller and Heckman represents a wide spectrum of companies and trade associations servicing a range of industries, including food and food additives, plastics, pesticides, industrial and specialty chemicals, drugs and medical devices, transportation, and telecommunications. The firm's practice covers the diverse regulatory areas that affect these industries, as well as business counseling and litigation issues. Our attorneys and scientists emphasize creative service to clients involved in the development of new products, services, and markets.
For more information, please click here
Copyright © Keller and Heckman LLPIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
New theory could lead to new generation of energy friendly optoelectronics: Researchers at Queen's University Belfast and ETH Zurich, Switzerland, have created a new theoretical framework which could help physicists and device engineers design better optoelectronics August 23rd, 2016
New flexible material can make any window 'smart' August 23rd, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016